Interpreting the significance of changes in health-related quality-of-life scores.
about
Evaluation of the Functional Assessment of Cancer Therapy-General (FACT-G) Spanish Version 4 in South America: classic psychometric and item response theory analysesOrder effects: a randomised study of three major cancer-specific quality of life instruments.Pursuing Quality in the Application of Bladder Cancer Quality of Life ResearchQuality of life in Arab women with breast cancer: a review of the literatureIs the Evaluation of Quality of Life in NSCLC Trials Important? Are the Results to be Trusted?Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical reviewSystematic review reveals lack of quality in reporting health-related quality of life in patients with gastroenteropancreatic neuroendocrine tumoursQuality of life assessment in patients with metastatic colorectal cancer receiving maintenance therapy after first-line induction treatment: a preplanned analysis of the phase III AIO KRK 0207 trial.Interdisciplinary care programme to improve self-management for cancer patients undergoing stem cell transplantation: a prospective non-randomised intervention study.Computerized adaptive testing for follow-up after discharge from inpatient rehabilitation: II. Participation outcomes.A longitudinal analysis of patient satisfaction with care and quality of life in ambulatory oncology based on the OUT-PATSAT35 questionnaireThe ProCaSP study: quality of life outcomes of prostate cancer patients after radiotherapy or radical prostatectomy in a cohort study.Review of health-related quality of life data in multiple myeloma patients treated with novel agents.Alternative methods of interpreting quality of life data in advanced gastrointestinal cancer patients.Rationale and design of the Adapted Physical Activity in advanced Pancreatic Cancer patients (APACaP) GERCOR (Groupe Coopérateur Multidisciplinaire en Oncologie) trial: study protocol for a randomized controlled trialNormative data of the EORTC QLQ-C30 for the German population: a population-based surveyModel-based methodology for analyzing incomplete quality-of-life data and integrating them into the Q-TWiST framework.Improving the quality and efficiency of follow-up after curative treatment for breast cancer--rationale and study design of the MaCare trial.Are the data on quality of life and patient reported outcomes from clinical trials of metastatic non-small-cell lung cancer important?Impact of neurocognitive deficits on patient-proxy agreement regarding health-related quality of life in low-grade glioma patients.The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative.The NORPEQ patient experiences questionnaire: data quality, internal consistency and validity following a Norwegian inpatient survey.Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF)A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer.Quality of life in patients with chordomas/chondrosarcomas during treatment with proton beam therapy.Self evaluation of communication experiences after laryngeal cancer - a longitudinal questionnaire study in patients with laryngeal cancerRaltitrexed-eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer.Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity.Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma.Phase II open-label study of sunitinib in patients with advanced breast cancer.A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07).Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulationsIntravenous ω-3 Fatty Acids Plus Gemcitabine.Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors.Multidisciplinary rehabilitation can impact on health-related quality of life outcome in radical cystectomy: secondary reported outcome of a randomized controlled trial.Health - related quality of life of Kuwaiti women with breast cancer: a comparative study using the EORTC Quality of Life QuestionnaireEffects of total laryngectomy on olfactory function, health-related quality of life, and communication: a 3-year follow-up study.Measuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reference men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P)Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: evaluation before a curative treatmentDistribution and determinants of patient satisfaction in oncology with a focus on health related quality of life.
P2860
Q24798364-DE11AD9E-F305-4B4B-8894-A0181DFA5272Q24811022-909A3FE9-A5E8-4AC2-B15B-471D62DF9AF0Q26744751-D76735FC-6E50-441A-B8C3-889D7796CF72Q26749529-E70D2F33-D333-4812-BD5F-7BC8D5E12C33Q27006021-8D6F3930-082E-478B-BDA2-FA0621AF95ACQ28068435-F9FC8245-3BA5-4218-8E55-BF093232CFF3Q28071978-889F2765-E71E-410D-AEA2-52173814361FQ30313818-79BFF715-45BE-4B48-B349-5531BC357347Q30315577-B86265D3-44E3-428E-9C64-1D5E1351A8E5Q30439889-9727BCF1-1711-47CD-8817-C8E8FAFCA96DQ30571630-DCB964EF-4D83-4F5F-BC2E-7DA66A0CE782Q30641961-2C67A508-E6A1-47D7-A140-FEC2928235B2Q30650394-CFA76BD9-3D4A-4435-AC2D-363F9F100AE2Q30665974-EA395ED8-0247-4A4E-8A39-B86572907DEFQ30667879-E4CD4396-6C1B-4CE2-91AA-0D8B2DB578B9Q30668968-09EC6DA5-DC8F-46FA-8CA8-3AC016987769Q30768835-63147AED-1900-4929-8B41-B63B940CE14FQ30828904-DB18E716-A916-4017-82F4-126564D1B864Q30830928-370ACE37-0577-4FF4-87C8-476430FB3C85Q30840511-E3CB5741-92FD-4388-BA4A-82C4E03C11BBQ31034367-4B068A30-968B-4801-AE3E-1EB7C8124367Q31127871-C47BEC04-2BB2-47D0-B230-B25F5AB9C276Q33265516-CDEBE292-02C6-4CF7-815C-1800B355004BQ33265964-D3E713B8-3D42-4B47-A31B-6298358B6241Q33274849-4A411CC5-B043-4FF1-8F6C-EF26B004ED6BQ33326017-42F7B4D2-919E-4087-85BF-0BC575FD655DQ33370390-69B162A5-C0BA-4CC2-9513-0A971635850CQ33375704-BD27681D-CDCC-467C-8B95-91153855855EQ33381056-87D074DF-B403-440D-996E-43D15BE23C5AQ33403848-E891B48F-0602-4DD7-BB93-F3865A8E45D4Q33411920-2634EB8E-4C5C-4660-AE3F-B5622CDFEAC0Q33417630-19D80B57-8124-42C6-8F50-0C561363C232Q33424793-D6498FD2-D8AA-4D33-82CA-A8480488FAEEQ33457264-64CFFC27-6767-4DD7-B633-3E7882BE2571Q33462438-1613E838-68AB-49EB-8E11-DDE409A552A4Q33479771-366510C7-F75F-4A86-BD72-D5B7DF602D95Q33488367-98B1073B-AB5F-4524-836F-7CCF67D0A174Q33495763-1D33BBD5-C3D9-4246-8AAD-8C2A0FFF8343Q33496347-90DA14BE-2373-49E9-B896-59C791CEF0FCQ33511664-6613E0DD-16B4-4AE0-B4A5-268A14B6C9E6
P2860
Interpreting the significance of changes in health-related quality-of-life scores.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Interpreting the significance of changes in health-related quality-of-life scores.
@en
Interpreting the significance of changes in health-related quality-of-life scores.
@nl
type
label
Interpreting the significance of changes in health-related quality-of-life scores.
@en
Interpreting the significance of changes in health-related quality-of-life scores.
@nl
prefLabel
Interpreting the significance of changes in health-related quality-of-life scores.
@en
Interpreting the significance of changes in health-related quality-of-life scores.
@nl
P2093
P1476
Interpreting the significance of changes in health-related quality-of-life scores.
@en
P2093
P304
P356
10.1200/JCO.1998.16.1.139
P407
P577
1998-01-01T00:00:00Z